Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000228442 | SCV000286115 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2023-12-16 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001002648 | SCV001160633 | likely benign | not specified | 2019-06-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002347874 | SCV002646403 | likely benign | Hereditary cancer-predisposing syndrome | 2017-11-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |